Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.7474
+0.0132 (1.80%)
At close: Jun 29, 2026, 4:00 PM EDT
0.7298
-0.0176 (-2.35%)
Pre-market: Jun 30, 2026, 8:37 AM EDT

Standard BioTools Revenue

Standard BioTools had revenue of $21.15M in the quarter ending March 31, 2026, with 4.57% growth. This brings the company's revenue in the last twelve months to $86.26M, down -3.71% year-over-year. In the year 2025, Standard BioTools had annual revenue of $85.33M, down -6.24%.

Revenue (ttm)
$86.26M
Revenue Growth
-3.71%
P/S Ratio
3.38
Revenue / Employee
$221,735
Employees
389
Market Cap
291.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202585.33M-5.68M-6.24%
Dec 31, 202491.01M-15.33M-14.42%
Dec 31, 2023106.34M8.39M8.57%
Dec 31, 202297.95M-32.63M-24.99%
Dec 31, 2021130.58M-7.56M-5.47%
Dec 31, 2020138.14M20.90M17.83%
Dec 31, 2019117.24M4.28M3.79%
Dec 31, 2018112.96M11.03M10.82%
Dec 31, 2017101.94M-2.51M-2.40%
Dec 31, 2016104.45M-10.27M-8.95%
Dec 31, 2015114.71M-1.74M-1.50%
Dec 31, 2014116.46M45.27M63.60%
Dec 31, 201371.18M18.85M36.02%
Dec 31, 201252.33M9.47M22.09%
Dec 31, 201142.87M9.31M27.73%
Dec 31, 201033.56M8.15M32.06%
Dec 31, 200925.41M10.07M65.58%
Dec 27, 200815.35M8.07M110.96%
Dec 29, 20077.28M877.00K13.71%
Dec 31, 20066.40M-1.28M-16.63%
Dec 31, 20057.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Orthofix Medical825.37M
Treace Medical Concepts207.32M
Quanterix144.98M
RxSight127.48M
Sight Sciences79.55M
Electromed71.75M
908 Devices57.80M
TriSalus Life Sciences44.88M
Revenue Rankings